Breaking News Instant updates and real-time market news.

HUM

Humana

$200.16

-1.9 (-0.94%)

, AET

Aetna

$124.88

-1.32 (-1.05%)

08:10
11/21/16
11/21
08:10
11/21/16
08:10

Humana is best positioned health insurer, says Wells Fargo

Wells Fargo believes that Humana (HUM) is the best positioned health insurer going forward, given Wells' estimate that it obtains 70%+ of its revenue from Medicare Advantage. The firm expects the latter program to be strengthened under the Trump Administration. Wells keeps an Outperform rating on Humana, which has agreed to be acquired by Aetna (AET).

HUM

Humana

$200.16

-1.9 (-0.94%)

AET

Aetna

$124.88

-1.32 (-1.05%)

HUM Humana
$200.16

-1.9 (-0.94%)

11/11/16
FBCO
11/11/16
UPGRADE
FBCO
Outperform
Humana upgraded to Outperform from Neutral at Credit Suisse
11/11/16
FBCO
11/11/16
UPGRADE
Target $210
FBCO
Outperform
Humana upgraded to Outperform on Medicare Advantage earnings at Credit Suisse
As previously reported, Credit Suisse upgraded Humana to Outperform from Neutral and raised its price target to $210 from $175. Analyst Scott Fidel said Trump's victory and the Republic sweep will be favorable for Medicare Advantage, adding to Humana's earnings.
11/11/16
11/11/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Disney (DIS) upgraded to Equal Weight from Underweight at Barclays with analyst Kannan Venkateshwar saying ESPN is "de-risked" going into 2017 after management quantified the impact of the new NBA contract. 2. Aetna (AET) and Humana (HUM) were upgraded to Outperform from Neutral at Credit Suisse, while the firm upgraded WellCare (WCG) to Neutral from Underperform. 3. Anadarko (APC) and EOG Resources (EOG) were upgraded to Buy from Neutral at Guggenheim. 4. Tiffany (TIF) upgraded to Outperform from Market Perform at Cowen with analyst Oliver Chen saying he believes the luxury market is coming back and Tiffany is well positioned and a trusted brand. 5. Vornado (VNO) upgraded to Buy from Neutral at BofA/Merrill with analyst James Feldman saying he believes the decision to spin DC and partner with JBG will allow management to focus on the New York City platform and notes the Penn Plaza corridor is rapidly improving. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/15/16
JEFF
11/15/16
NO CHANGE
Target $230
JEFF
Buy
Humana price target raised to $230 from $206 at Jefferies
Jefferies analyst David Windley raised his price target for Humana to $230 after meeting with CFO Brian Kane. The potential to double Medicare Advantage enrollment under a Paul Ryan-type plan "introduces a significant upside scenario," Windley tells investors in a research note. The analyst keeps a Buy rating on the shares.
AET Aetna
$124.88

-1.32 (-1.05%)

11/11/16
11/11/16
UPGRADE
Target $135

Outperform
Aetna upgraded to Outperform following Trump win at Credit Suisse
As previously reported, Credit Suisse upgraded Aetna to Outperform from Neutral and raised its price target to $135 from $120. Analyst Scott Fidel said Trump's victory and the Republic sweep will be favorable for Medicare Advantage, which Aetna has been a leader in both enrollment growth and star ratings, and sees upside potential from result potential repeal of several onerous insurance market reforms of the ACA that have "crippled" Aetna's margins.Medicare
11/14/16
BERN
11/14/16
DOWNGRADE
BERN
Market Perform
Aetna downgraded to Market Perform from Outperform at Bernstein
11/15/16
ARGS
11/15/16
NO CHANGE
ARGS
Aetna price target raised to $145 from $130 at Argus
Argus analyst David Toung says that Aetna's Q3 results were "strong," excluding its ACA-compliant exchange plans. Toung believes that the Trump Administration could be more likely to approve the company's merger with Humana (HUM) than a Democratic administration would have been. He keeps a Buy rating on the shares.

TODAY'S FREE FLY STORIES

04:55
06/26/17
06/26
04:55
06/26/17
04:55
General news
Breaking General news story  »

3-Month Bill Auction to…

04:55
06/26/17
06/26
04:55
06/26/17
04:55
General news
Breaking General news story  »

San Francisco Federal…

MDR

McDermott

$7.13

0.3 (4.39%)

, MDSO

Medidata

$79.90

-0.35 (-0.44%)

04:55
06/26/17
06/26
04:55
06/26/17
04:55
Hot Stocks
Breaking Hot Stocks news story on McDermott, Medidata »

McDermott to replace…

MDR

McDermott

$7.13

0.3 (4.39%)

MDSO

Medidata

$79.90

-0.35 (-0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 28

    Jun

  • 29

    Jun

  • 11

    Jul

BASFY

BASF

$95.05

-0.18 (-0.19%)

04:55
06/26/17
06/26
04:55
06/26/17
04:55
Conference/Events
BASF management to meet with Evercore ISI »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

BOBE

Bob Evans

$72.53

0.24 (0.33%)

04:55
06/26/17
06/26
04:55
06/26/17
04:55
Conference/Events
Bob Evans management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

GLYC

GlycoMimetics

$13.41

1.31 (10.83%)

04:55
06/26/17
06/26
04:55
06/26/17
04:55
Conference/Events
GlycoMimetics management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

04:55
06/26/17
06/26
04:55
06/26/17
04:55
General news
Chicago Fed National Activity Index Level to be reported at 08:30 »

May Chicago Fed National…

04:55
06/26/17
06/26
04:55
06/26/17
04:55
General news
Breaking General news story  »

6-Month Bill Auction to…

MDSO

Medidata

$79.90

-0.35 (-0.44%)

, PVTB

PrivateBancorp

04:55
06/26/17
06/26
04:55
06/26/17
04:55
Hot Stocks
Medidata to replace PrivateBancorp in S&P 400 at open on 6/26 »

Canadian Imperial Bank of…

MDSO

Medidata

$79.90

-0.35 (-0.44%)

PVTB

PrivateBancorp

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 28

    Jun

  • 29

    Jun

  • 11

    Jul

MFG

Mizuho Financial Group

04:55
06/26/17
06/26
04:55
06/26/17
04:55
Conference/Events
Mizuho Financial Group management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

LULU

lululemon

$55.37

1.12 (2.06%)

04:55
06/26/17
06/26
04:55
06/26/17
04:55
Conference/Events
lululemon management to meet with Barclays »

Meeting with CEO Laurent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

AYR

Aircastle

$21.17

0.04 (0.19%)

04:55
06/26/17
06/26
04:55
06/26/17
04:55
Conference/Events
Aircastle management to meet with Oppenheimer »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

EXLS

ExlService

$55.05

0.15 (0.27%)

04:55
06/26/17
06/26
04:55
06/26/17
04:55
Conference/Events
ExlService management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 27

    Jun

  • 28

    Jun

  • 29

    Jun

NBIX

Neurocrine

$47.35

0.23 (0.49%)

04:55
06/26/17
06/26
04:55
06/26/17
04:55
Conference/Events
Neurocrine management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 27

    Jun

  • 28

    Jun

  • 29

    Jun

  • 29

    Jun

GLYC

GlycoMimetics

$13.41

1.31 (10.83%)

04:55
06/26/17
06/26
04:55
06/26/17
04:55
Conference/Events
GlycoMimetics management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

04:55
06/26/17
06/26
04:55
06/26/17
04:55
General news
Breaking General news story  »

4-Week Bill Announcement…

XOXO

XO Group

$17.60

0.1 (0.57%)

04:55
06/26/17
06/26
04:55
06/26/17
04:55
Conference/Events
XO Group management to meet with B. Riley »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

04:55
06/26/17
06/26
04:55
06/26/17
04:55
General news
Durable Goods Orders to be reported at 08:30 »

May Durable Goods Orders…

04:55
06/26/17
06/26
04:55
06/26/17
04:55
General news
Dallas Fed Mfg Survey General Activity Index to be reported at 10:30 »

June Dallas Fed Mfg…

04:55
06/26/17
06/26
04:55
06/26/17
04:55
Conference/Events
JPMorgan life sciences analyst holds an analyst/industry conference call »

Life Science Tools and…

SAVE

Spirit Airlines

$52.55

0.02 (0.04%)

04:55
06/26/17
06/26
04:55
06/26/17
04:55
Conference/Events
Spirit Airlines management to meet with Raymond James »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 27

    Jun

04:55
06/26/17
06/26
04:55
06/26/17
04:55
General news
Durable Goods Orders Ex-transportation to be reported at 08:30 »

May Durable Goods Orders…

04:40
06/26/17
06/26
04:40
06/26/17
04:40
General news
FX Action: The yen is under the cosh »

FX Action: The yen is…

03:10
06/26/17
06/26
03:10
06/26/17
03:10
General news
FX Update: The dollar has traded steady-to-softer »

FX Update: The dollar has…

03:05
06/26/17
06/26
03:05
06/26/17
03:05
General news
FX Action: USD-CAD is softer today »

FX Action: USD-CAD is…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.